FDA begins attempts to review child formulas

The Food and Drug Administration (FDA) on Tuesday announced a new initiative that aimed at reviewing the elements of the infant formula under the title “Operation Stork Speed” and expanded the available options.

According to the FDA, the goal of its new initiative is to ensure the quality, protection, nutritional adequateness and elasticity of the supply of domestic child formulas.

In 2022, the supply of US child sources was prevented after the temporary closure of Michigan facilities in Abbott Nutrition due to bacteria pollution. The FDA stopped this facility for months and a recovery was issued nationwide.

Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement, “The FDA will use all its resources and authorities to ensure that the FDA is safe and healthy for the family and children,” Health and Human Services Secretary Robert F. Kennedy Jr. said a state of critic.

The FDA’s response to the child source crisis in 2022 was scrutinized, with the Inspector General’s Office for the Department of Health and Human Services, the company was dangerously slow to respond to the conditions on the facility. From this the blockback reorganizes its structure in the part of the FDA in 2024.

In his announcement on Tuesday, the FDA says it has said that the adequate adequateness of nutrients and the infant will support the supply of sources. These include “The first extensive update and review of infant formulas by the FDA since 1998,” include “increase tests for heavy metals and increase personal import policies.

The company also says that they will encourage companies to develop new child formulas.